LIBOR: Pomerantz is lead counsel on behalf of all lending institutions in the United States in a class action arising out of the LIBOR rate-fixing scandal, which impacted trillions of dollars in investments.
Sanofi: Pomerantz leads a class action against the global company for falsely representing its operations while its executives funneled tens of millions of dollars into illegal incentives to get Sanofi’s diabetes drugs prescribed and sold.
SAC Capital Advisors: In this insider trading case, Pomerantz’s analysis of the statute of limitations led to an additional two-year period for which SAC must answer to claims.
BP PLC: Pomerantz’s cutting-edge legal theory for investors who purchase securities on foreign exchanges is overcoming obstacles created by SCOTUS in Morrison.
ADDITIONAL SUCCESSES IN
POMERANTZ'S LANDMARK BP LITIGATION
October 2014, Pomerantz once again secured crucial victories in its ground-breaking litigation over British Petroleum’s 2010 Gulf of Mexico oil spill. This time, Pomerantz established the right of individual foreign investors who purchased foreign-traded shares of a foreign corporation to pursue claims for securities fraud in a U.S. court, thereby overcoming obstacles created by the U.S. Supreme Court’s decision in Morrison v. Nat’l Australia Bank Ltd.
A year prior, Pomerantz defeated BP’s motion to dismiss similar claims by individual U.S. public pension funds. Read More